Looking for leads, investment insights, or competitive intelligence?
News about Bristol-Myers Squibb
A combination of Merck's Keytruda and chemotherapy cut lung cancer death rates in half.
Merck gained more than $5.7 billion in market value Monday.
Drug giants Merck and Bristol-Myers Squibb felt the pain, too.
The finding could result in annual sales of $4.6 billion by 2023.
The ruling led a St. Louis judge at J&J's urging to declare a mistrial in the latest talc case.